- Home
- ADTX vs ONFO Comparison
ADTX vs ONFO Comparison
Compare ADTX & ONFO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADTX
- ONFO
- Stock Information
- Founded
- ADTX 2017
- ONFO 2018
- Country
- ADTX United States
- ONFO United States
- Employees
- ADTX N/A
- ONFO N/A
- Industry
- ADTX Biotechnology: Pharmaceutical Preparations
- ONFO Computer Software: Programming Data Processing
- Sector
- ADTX Health Care
- ONFO Technology
- Exchange
- ADTX Nasdaq
- ONFO Nasdaq
- Market Cap
- ADTX 5.3M
- ONFO 6.2M
- IPO Year
- ADTX 2020
- ONFO 2022
- Fundamental
- Price
- ADTX $5.66
- ONFO $0.91
- Analyst Decision
- ADTX
- ONFO
- Analyst Count
- ADTX 0
- ONFO 0
- Target Price
- ADTX N/A
- ONFO N/A
- AVG Volume (30 Days)
- ADTX 8.1M
- ONFO 31.1K
- Earning Date
- ADTX 05-19-2025
- ONFO 05-20-2025
- Dividend Yield
- ADTX N/A
- ONFO N/A
- EPS Growth
- ADTX N/A
- ONFO N/A
- EPS
- ADTX N/A
- ONFO N/A
- Revenue
- ADTX $133,985.00
- ONFO $6,590,171.00
- Revenue This Year
- ADTX $95.61
- ONFO $133.59
- Revenue Next Year
- ADTX $1,584.79
- ONFO N/A
- P/E Ratio
- ADTX N/A
- ONFO N/A
- Revenue Growth
- ADTX N/A
- ONFO 29.25
- 52 Week Low
- ADTX $4.11
- ONFO $0.39
- 52 Week High
- ADTX $35,000.00
- ONFO $1.88
- Technical
- Relative Strength Index (RSI)
- ADTX 33.28
- ONFO 40.30
- Support Level
- ADTX $4.17
- ONFO $0.61
- Resistance Level
- ADTX $5.44
- ONFO $1.02
- Average True Range (ATR)
- ADTX 1.67
- ONFO 0.11
- MACD
- ADTX 0.41
- ONFO -0.02
- Stochastic Oscillator
- ADTX 9.61
- ONFO 40.63
About ADTX Aditxt Inc.
Aditxt Inc is a life sciences company that develops, builds, and grows innovations with a focus on monitoring and modulating the immune system. It develops products designed to induce tolerance to transplanted organs. Its portfolio consists of two programs Adimune and AditxtScore. It firm's immunosuppressive (anti-rejection) drugs have made possible life-saving organ transplantation procedures and blocking of unwanted immune responses in autoimmune diseases. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) ADI-100, which utilizes a novel approach that mimics the way bodies naturally induce tolerance to tissues.
About ONFO Onfolio Holdings Inc.
Onfolio Holdings Inc actively manages small online businesses that operate in sectors with long-term growth opportunities, have positive and stable cash flows, face minimal threats of technological or competitive obsolescence, and can be managed by existing teams or have management teams largely in place.